Cargando…
Treatment of co-infection with bancroftian filariasis and onchocerciasis: a safety and efficacy study of albendazole with ivermectin compared to treatment of single infection with bancroftian filariasis
BACKGROUND: In order to use a combination of ivermectin and albendazole for the elimination of lymphatic filariasis, it is important to assess the potential risk of increased adverse events in individuals infected with both lymphatic filariasis and onchocerciasis. We compared the safety and efficacy...
Autores principales: | Makunde, William H, Kamugisha, Leo M, Massaga, Julius J, Makunde, Rachel W, Savael, Zakana X, Akida, Juma, Salum, Fred M, Taylor, Mark J |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2003
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC293471/ https://www.ncbi.nlm.nih.gov/pubmed/14613509 http://dx.doi.org/10.1186/1475-2883-2-15 |
Ejemplares similares
-
Current Epidemiological Assessment of Bancroftian Filariasis in Tanga Region, Northeastern Tanzania
por: Mshana, Happyness J., et al.
Publicado: (2016) -
Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis
por: Chhonker, Yashpal S., et al.
Publicado: (2023) -
Mapping of Bancroftian Filariasis in Cameroon: Prospects for Elimination
por: Nana-Djeunga, Hugues C., et al.
Publicado: (2015) -
The Burden of Bancroftian Filariasis in Nigeria: A Review
por: Hussaini, Adamu, et al.
Publicado: (2020) -
Current Evidence on the Use of Antifilarial Agents in the Management of Bancroftian Filariasis
por: Fernando, Sumadhya Deepika, et al.
Publicado: (2011)